Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data

BACKGROUND: For stroke prevention in patients with atrial fibrillation (AF), direct oral anticoagulants (DOACs) have been increasingly prescribed instead of vitamin-K-antagonists (VKA). For some patients a lower dosage of DOACs (ld-DOACs) is recommended. Ld-DOAC prescribing seems to be common, altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Warkentin, Lisette, Hueber, Susann, Deiters, Barthold, Klohn, Florian, Kühlein, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137171/
https://www.ncbi.nlm.nih.gov/pubmed/35619140
http://dx.doi.org/10.1186/s12959-022-00389-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137171/
https://www.ncbi.nlm.nih.gov/pubmed/35619140
http://dx.doi.org/10.1186/s12959-022-00389-9

Ejemplares similares